tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO

Crescent Biopharma (CBIO) Revenue

Compare
1,025 Followers

Crescent Biopharma Revenue

Crescent Biopharma had a revenue of 10.84M in the quarter ending Dec 31, 2025, with -64.52%. This bring the company's revenue in the last twelve months to 41.41M, Decreased 35.48%. In the fiscal year ending Dec 31, 2025, Crescent Biopharma had annual revenue of 10.84M with Infinity% growth.
Revenue (ttm)
41.41M
Revenue Growth
-100.00%
P/S Ratio
28.44
Revenue/Employee
$264,488
Employees
41
Market Cap
$308.36M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
10.84M+∞%
Dec 31, 2024
-10.00K-100.00%
Dec 31, 2023
10.00K-65.00K-86.67%
Dec 31, 2022
75.00K-1.08M-93.53%
Dec 31, 2021
1.16M-9.00M-88.59%
Dec 31, 2020
10.16M+∞%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017